Regeneron Pharmaceuticals Inc – Buy Top Biotech Stocks

Regeneron has been making news lately as its drug Dupixent recently yielded positive results in a Phase 3 trial. The drug is focused on treating atopic dermatitis among young children between the ages of 6 months and five years. The drug Dupixent has the potential to become one of the top-selling treatments globally over the […]